期刊文献+
共找到259篇文章
< 1 2 13 >
每页显示 20 50 100
NDRG2调控IRE1α-XBP1介导内质网应激逆转ER+乳腺癌他莫昔芬耐药
1
作者 王守莹 杜彦艳 +5 位作者 曹鹏 刘文宇 齐俊愉 石炜业 张春晓 周晓雷 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2024年第10期1409-1416,共8页
他莫昔芬(tamoxifen,TAM)作为雌激素受体阳性(estrogen receptor,ER+)乳腺癌的一线化疗药物使大多数患者受益,但原发性和继发性耐药问题严重影响临床治疗效果。深入研究ER+乳腺癌TAM耐药机制,改善治疗效果是当前亟待解决的问题。抑癌因... 他莫昔芬(tamoxifen,TAM)作为雌激素受体阳性(estrogen receptor,ER+)乳腺癌的一线化疗药物使大多数患者受益,但原发性和继发性耐药问题严重影响临床治疗效果。深入研究ER+乳腺癌TAM耐药机制,改善治疗效果是当前亟待解决的问题。抑癌因子NDRG2(N-myc downstream regulated gene 2,NDRG2)在肿瘤发生发展中发挥重要作用,但是否参与ER+乳腺癌TAM耐药尚不清楚。本研究旨在探明NDRG2在ER+乳腺癌TAM耐药中发挥的作用和机制。通过RT-PCR与免疫印迹分析对比TAM敏感型和耐药型ER+乳腺癌细胞发现,NDRG 2的mRNA转录水平和蛋白质翻译水平在TAM耐药细胞中表达显著下调,且与耐药能力负相关(P<0.001);CCK-8细胞毒性实验和软琼脂克隆形成实验证实,在耐药细胞中过表达NDRG2可显著降低TAM药物半抑制浓度IC 50和软琼脂克隆形成率(P<0.001),逆转耐药表型。分子机制上,X-box结合蛋白1(X-box binding protein 1,XBP1)mRNA剪切实验与内质网相关降解(endoplasmic-reticulum associated degradation,ERAD)报告蛋白的结果显示,过表达NDRG2可增强耐药细胞中剪切型XBP1s mRNA转录与ERAD报告蛋白CD3ε-YFP表达(P<0.001),引发耐药细胞内质网强应激反应;免疫印迹检测结果显示,过表达NDRG2可显著提高耐药细胞中内质网应激感受器肌醇需要激酶1α(inositol requiring enzyme 1,IRE1α)的磷酸化水平及其下游因子,例如内质网EIP辅助因子(endoplasmic reticulum-localized DnaJ 4,ERdj4)、PKR蛋白激酶的细胞抑制剂(cellular Inhibitor of the PKR protein kinase,P58 IPK)、α甘露糖苷酶样应激蛋白(er degradation enhancingαmannosidase likeprotein,EDEM)和蛋白质二硫键异构酶家族A成员5(protein disulfide isomerase family a member 5,PDIA5)的表达水平(P<0.001)。小鼠异种移植瘤研究进一步证实,在耐药细胞中过表达NDRG2可增强TAM治疗效果,显著抑制耐药移植瘤生长(P<0.001)。以上研究结果表明,通过提高耐药细胞中NDRG2表达,增强TAM治疗引发的内质网强烈应激,可逆转ER+乳腺癌细胞耐药性,改善TAM治疗效果。研究结果为解决ER+乳腺癌TAM耐药问题提供了新的思路和有价值的潜在药物靶点。 展开更多
关键词 雌激素受体阳性乳腺癌 N-myc下游调节基因2 他莫昔芬 耐药 内质网应激
下载PDF
The Effect of GnRHa Induced Superovulation on Endometrial Morphology and Estrogen Receptor and Progesterone Receptor in Mouse 被引量:2
2
作者 Yong-MiaoPAN Yi-FuSHI 《Journal of Reproduction and Contraception》 CAS 2002年第3期152-157,共6页
To evaluate the effect of GnRHa induced superovulation protocol on endometrial morphology and function. Material & Methods Forty ICR mice were randomly allocated into 4 groups, among them, 2 experimental gro... To evaluate the effect of GnRHa induced superovulation protocol on endometrial morphology and function. Material & Methods Forty ICR mice were randomly allocated into 4 groups, among them, 2 experimental groups were injected with GnRHa+HMG+hCG, another 2 groups were given saline of same volume as control group. The uterine tissues were investigated at 24 h and 48 h after administration (experimental group) or ovulation (control group).The endometrial thickness, the size of gland and glandular lumen, the total area of glandular cells, the average height of glandular epithelium were measured from routine histological slides using computerized image analysis. The SP immunohistochemistry techniques with monoclonal antibodies were employed to semi quantitatively analize the estrogen receptor (ER) and progesterone receptor (PR) in glandular cells. Results The endometrial thickness was not significantly different between experimental groups and control groups at 24 h and 48 h (P>0.05).The average area, perimeter, maximal diameter of single gland and glandular lumen, the total area, average height of glandular epithelium in experimental groups were significantly smaller than those of in control groups at equivalent time stages (all P<0.01). The asynchronous development of gland epithelium and stroma cells, namely, pesudostratified glandular epithelium and predecidual changes of stroma cells were seen at same time in experimental groups. The positive percentage (%) and expression intense of ER and PR in glandular epithelium cells were significantly lower in experimental groups than in control groups (P<0.05). Conclusion The protocol with GnRHa had a negative effect on endometrial histological structure and down regulated the express of ER and PR, suggesting that this protocol effect on the endometrial morphology and function and could not facilitate the formation of a physiologic endometrium completely, which may be one of the causes of low pregnancy rates. 展开更多
关键词 GNRHA SUPerOVULATION ENDOMETRIUM HISTOLOGY estrogen receptor (er) progesterone receptor (PR) mice
下载PDF
Association between estrogen receptor β gene Rsa1 polymorphism and depressive disorder in peri-menopausal and menopausal women 被引量:3
3
作者 于学文 任永惠 +4 位作者 李学成 高成阁 李芬 韩蓁 李旭 《Journal of Medical Colleges of PLA(China)》 CAS 2005年第2期102-105,共4页
Objective: To investigate estrogen receptor β (ERβ) gene Rsa1 polymorphism and concentration of estrogen, FSH and LH in serum in peri-menopausal and menopausal women with depressive disorder. Methods: Seventy-four p... Objective: To investigate estrogen receptor β (ERβ) gene Rsa1 polymorphism and concentration of estrogen, FSH and LH in serum in peri-menopausal and menopausal women with depressive disorder. Methods: Seventy-four peri-menopausal and menopausal women with depressive disorder met ICD-10 and CCMD-3 assessment criteria for depressive disorder were recruited. ERβ gene Rsa1 polymorphism was analyzed with PCR-RFLP. Serum levels of estrogen, FSH and LH were measured by magnetism-ELISA. Results: The respective frequency of ERβ gene Rsa1 polymorphism was no significant difference between women with depressive disorder and the healthy women (χ 2=1.106,P>0.05). The serum level of estrogen was lower in women with depressive disorder than in the healthy women (P<0.05). No difference was found for FSH and LH between two groups. Conclusion: ERβ gene Rsa1 polymorphism may be not associated with depressive disorder in the peri-menopausal and menopausal women. The serum level of estrogen is associated with depressive disorder in the peri-menopausal and menopausal women. 展开更多
关键词 depressive disorder estrogen estrogen receptor β (erβ) restriction fragment length polymorphism (RFLP)
下载PDF
Increased Midkine and Estrogen Receptor-β Expression in Human Non-Small Cell Lung Cancer 被引量:1
4
作者 Shi-hua Zhang Guang-feng Zhao +2 位作者 Ya-hong Huang Kai-hua Lu Ya-yi HOU 《Chinese Journal of Cancer Research》 SCIE CAS CSCD 2009年第4期255-264,共10页
Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved... Objective: Midkine (MK), a new member of the heparin-binding growth factor family, has been found recently to have a high expression level in many tumor specimens including lung carcinoma. Estrogens may be involved in lung carcinogenesis, and estrogen receptors, mainly estrogen receptor-β (ER-β), are present and functional in normal lung and tumor cell lines and tissues. In addition, estrogens and growth factors may promote the progression of human non-small cell lung cancer (NSCLC). Previously, we have immunohistochemically demonstrated that MK and ER-β proteins were overexpressed in NSCLC and their expression levels were both significantly negatively correlated with the pathological classification. The purpose of this study was to further verify their expression and its correlation with NSCLC. Methods: Taking NSCLC tissues and their corresponding paraneoplastic and normal lung as research objects, we further examined the expression of MK and ER-β by meas of RT-PCR, in situ hybridization and Western blot analyses at the levels of messenger RNA (mRNA) and protein, respectively. Results: The increased MK and ER-β mRNA expression was found in NSCLC by RT-PCR and in situ hybridization analyses. Furthermore, Western blot analysis also displayed increased expression of MK and ER-β proteins in NSCLC. Finally, their correlation analysis at the levels of mRNA and protein expression in NSCLC demonstrated that MK protein level was significantly correlated to estrogen receptor-β (P〈0.01, rs=0.535); in spite of their correlation at the mRNA level, there was no remarkable difference between MK and ER-β (P〉0.05, rs=0.178). Conclusion: All these results in the present study confirmed that MK and ER-β were overexpressed in human NSCLC. 展开更多
关键词 Midkine (MK) estrogen receptor er-β) Non-small cell lung cancer (NSCLC)
下载PDF
The expression of estrogen receptors in thyroid cancer and its significance 被引量:1
5
作者 Yuxuan Che Huamin Qin +2 位作者 Xiaolei Ding Xiuhua Sun Lifen Wang 《Oncology and Translational Medicine》 2017年第3期127-130,共4页
Objective The study aimed to detect the expression of estrogen receptors(ERs) in thyroid cancer and investigate the correlation between their expression and clinical features and different pathological types.Methods T... Objective The study aimed to detect the expression of estrogen receptors(ERs) in thyroid cancer and investigate the correlation between their expression and clinical features and different pathological types.Methods The expression of ERs in 56 samples of thyroid cancer tissues was detected by an immunochemical approach. The expression of ERs in thyroid cancer tissues and different pathological types were analyzed using the χ~2 test. Results The number of cases with positive expression of ER in thyroid cancer tissues was 36. The number of papillary thyroid cancers(PTCs) was 48, with positive expression of ERs in 32 cases. The number of follicular thyroid cancers was 4, with positive expression of ERs in 2 cases. The number of medullary thyroid cancers was 4, with negative expression of ERs in all cases. The difference between the expression and different pathological types showed statistical significance. The expression of ERs showed no correlation with sex, age, or TNM stage, with no statistical significance. However, the expression of ERs was correlated with metastasis of lymph nodes, which had statistical significance. The expression of ERs was negatively correlated with pathological types and metastasis of lymph nodes. The correlated coefficient index was –0.313 and –0.334, respectively. Conclusion The expression of ERs showed no correlation with sex, age, or TNM stage, but was negatively correlated with pathological types and metastasis of lymph nodes. 展开更多
关键词 thyroid cancer estrogen receptorer pathological type
下载PDF
Studies of the Expression of Estrogen Receptor Gene in the Rat Uterus during the Estrous Cycle and Periimplantational Period
6
作者 张沅 秦武轩 +3 位作者 赵炳顺 范植明 邹继超 张永莲 《Journal of Reproduction and Contraception》 CAS 1995年第2期65-73,共9页
The correlation or serum estradiol concentrstion and uterine estrogen receptor (ER) gene expression (ERn and ERc quantitated by Dextrsn Coat Charcoal assay and ER mRNA by Northern blotting) was studied during the rat ... The correlation or serum estradiol concentrstion and uterine estrogen receptor (ER) gene expression (ERn and ERc quantitated by Dextrsn Coat Charcoal assay and ER mRNA by Northern blotting) was studied during the rat estrous cycle and early Pregnant stage (dl-d10). The ER gone expression was up - regulated by estrogen and the levels of ER mRNA synchronized with the changes of ER protein, suggesting that estrogen influenced the trsnscriPtional step of the ER gene. Post-coitum ER expression increased with the serum estrsdiol progressively, reached a peak on d4-ds (Just before implantation), but drastically dropped to the nadir on d6-d7 (during implantation) and then recovered. It was of interest to discover that ER mRNA level in the nonimplantstion sites (NIS) of uterus was much higher than that in the implantstion sites (IS). 展开更多
关键词 IMPLANTATION Estradiol (E_2) estrogen receptor (er) gene mRNA
下载PDF
Correlation of Hormonal Receptors Estrogen Receptor, Progesterone Receptor and Her-2/Neu with Tumor Characteristics in Breast Carcinoma: Study of 100 Consecutive Cases
7
作者 Priyadarshini Biswal Susmita Behera +4 位作者 Asaranti Kar Dilleswari Pradhan Pradeep Kumar Behera Subrat Burma Chandraprava Mishra 《International Journal of Clinical Medicine》 2015年第12期961-966,共6页
Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of h... Introduction-Breast cancer is the most common cancer and leading cause of death in women. In India, its incidence is rapidly rising over last few decades. Present study is aimed to study the pattern of expression of hormonal receptors and Her-2/neu in invasive breast carcinoma and to correlate estrogen receptor (ER), progesterone receptor (PR) and Her-2/neu expressions with various clinicopathological parameters. Material and methods: The present study was carried out in Department of Pathology, S.C.B. Medical College, Cuttack in the year 2013 taking consecutive 100 cases. Routine H&E staining for histological diagnosis and IHC analysis for ER, PR and Her 2/neu was carried out in all 100 cases of breast malignancies. Results: 99% of cases are invasive breast carcinoma, not otherwise specify (IDC-NOS). The age ranges from 23 years to 72 years. Majority of tumors are of grade 2 (70%) followed by grade 3 (30%). ER PR and Her-2/neu expression are seen in 45%, 35% and 30% respectively. Triple negative cases comprise 35%. Higher number of grade 2 tumor shows ER, PR positivity as compared to grade 3 tumors. Her-2/neu expression does not show any significant correlation with age or lymph node status of the patient. Conclusion: ER and PR expression in breast cancers in the current study are found to be comparable to the findings of other authors, but the frequency of HER-2/neu expression is slightly higher. Significant correlation is observed between hormonal receptor status and the grade of the tumor. Inverse relationship is found between Her-2/neu expression and ER, PR receptor status. Her-2/neu expression is increased with size and high grade of tumor. 展开更多
关键词 Breast Carcinoma estrogen receptor (er) PROGESTerONE receptor (PR) Her-2/NEU IMMUNOHISTOCHEMISTRY
下载PDF
Effects of Estrogen on ER, NGF, and ChAT Expression in Cerebellum of Aging Female Sprague-Dawley Rat 被引量:1
8
作者 CHEN Zheng-li FAN Guang-li +2 位作者 LUO Qi-hui ZHU Chun-mei HUANG Yi-dan 《Agricultural Sciences in China》 CAS CSCD 2007年第3期368-374,共7页
This article discusses the effects of estrogen on the expression of estrogen receptor (ER), nerve growth factor (NGF), and choline acetyltransferase (CHAT) in the cerebellum of rats. The model of aging female ra... This article discusses the effects of estrogen on the expression of estrogen receptor (ER), nerve growth factor (NGF), and choline acetyltransferase (CHAT) in the cerebellum of rats. The model of aging female rat was established to study the expression and distribution of ER, NGF, and ChAT in the cerebellum following 17β-estradiol treatment using the technique of immunohistochemical ultrasensitive SP in sprague-dawley rat. The immunoreactive productions were distributed in stratum Purkinje cell, nucleus dentatus, nucleus interpositus, and nucleus fastigii of cerebellum, and the ER positive production was mainly located in the plasma, cytoplasmic membrane, and neurite, and also existed in nucleus. The general tendency of the expression of ER, NGF, and ChAT positive production in the cerebellum cortex and nuclei of aging rat significantly decreases, while the intensity and quantity of the immunoreactive production ascends predominantly after 17β-estradiol treatment. Simultaneously, the positive neurite of Purkinje cell shows a similar tendency. The above- mentioned results suggest that the estrogen upregulates the expression of NGF and CHAT, and plays a vital role in sustaining and protecting the structure and function of cerebellum neurons. Furthermore, the similarity of their changing tendency implies that they were correlated and cooperated during the course in effect of estrogen on cerebellum. It also showed that the action of estrogen in cerebellum could be via genomic and nongenomic mechanism. 展开更多
关键词 estrogen receptor er nerve growth factor (NGF) choline acetyltransferase (CHAT) immunohistochemical ultrasensitive SP CerEBELLUM rat
下载PDF
Expressions of Estrogen Receptorαand β in the Development and Maturation of Rat Heart
9
作者 Zong-Wen TIAN Jian SONG Qiao WANG Xiao-Nin YANG Xi-Chang CHEN Bang-Chang CHENG(Faculty of Anatomy and Embryology,Wuhan University School of Medicine,Wuhan 430071, China) 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2005年第S1期41-42,共2页
关键词 and in the Development and Maturation of Rat Heart Expressions of estrogen receptor er
下载PDF
ER、PR、VEGF及其受体在原因不明月经过少发病机制中的作用 被引量:25
10
作者 袁瑞 乐爱文 +1 位作者 姚珍薇 耿力 《重庆医科大学学报》 CAS CSCD 2007年第1期48-51,共4页
目的:通过对子宫内膜组织中雌激素受体(ER)、孕激素受体(PR)、血管内皮生长因子((VEGF)及其受体(KDR)表达的研究,探讨原因不明月经过少的发病机制。方法:2004年9月至2005年12月重庆医科大学附属第一医院以前瞻性方法观察月经过少组(观察... 目的:通过对子宫内膜组织中雌激素受体(ER)、孕激素受体(PR)、血管内皮生长因子((VEGF)及其受体(KDR)表达的研究,探讨原因不明月经过少的发病机制。方法:2004年9月至2005年12月重庆医科大学附属第一医院以前瞻性方法观察月经过少组(观察组)和正常月经组(对照组)患者各40例,采用酶联免疫测定法,测定两组血清6项性激素,包括卵泡刺激素(FSH)、黄体生成素(LH)、雌激素(E2)、催乳素(PRL)、孕酮(P)及睾酮(T),通过免疫组化半定量测定两组子宫内膜组织中ER、PR、VEGF、KDR的表达水平。结果:两组血清性激素水平FSH、LH、E2、PRL、P及T差异无显著性意义(P>0.05);观察组子宫内膜ER、VEGF和KDR的表达明显低于对照组(P值分别为<0.05);两组子宫内膜腺上皮细胞PR的表达差异无显著性意义(P>0.05)。结论:子宫内膜组织中ER、VEGF和KDR的异常表达可能导致原因不明的月经过少。 展开更多
关键词 月经过少 血管内皮生长因子 雌激素受体 孕激素受体
下载PDF
米非司酮下调不全流产患者蜕膜雌激素受体(ER)及孕激素受体(PR)表达 被引量:26
11
作者 诸葛听 李斌 黄紫蓉 《复旦学报(医学版)》 CAS CSCD 北大核心 2014年第3期335-339,共5页
目的了解不同剂量米非司酮对人工流产术后不全流产残留物中绒毛膜促性腺激素-β(β-human chorionic gonadotrophin,β-hCG)及雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)表达的影响。方法 60例2009年1至... 目的了解不同剂量米非司酮对人工流产术后不全流产残留物中绒毛膜促性腺激素-β(β-human chorionic gonadotrophin,β-hCG)及雌激素受体(estrogen receptor,ER)、孕激素受体(progesterone receptor,PR)表达的影响。方法 60例2009年1至9月自愿在复旦大学附属妇产科医院计划生育门诊就诊的早孕人工流产术后不全流产妇女,随机分为4组:A、B、C组术前分别服用米非司酮1 400 mg(100mg,bid×7d)、700 mg(50mg,bid×7d)、350 mg(25 mg,bid×7d),D组为对照组,每组各1 5例。除D组直接行清宫术,其他组于停药后行清宫术。应用免疫组织化学EnVision法染色,半定量测定残留物中β-hCG及ER、PR水平。结果 4组β-hCG在绒毛滋养叶细胞胞质的表达差异无统计学意义(P>0.05)。ER、PR在蜕膜上皮细胞和间质细胞核中的表达,实验组较对照组表达均降低,差异均有统计学意义(P<0.05)。经两两秩和检验(修正α=0.05):ER在蜕膜上皮细胞核中的表达为A组较C、D组明显降低,差异有统计学意义(P<0.05);ER在蜕膜间质细胞核中的表达为A组较其他组明显降低,差异有统计学意义(P<0.05);A、B、C组较D组表达降低,差异有统计学意义(P<0.05)。PR在蜕膜上皮细胞核中,A、B、C组较D组表达降低,差异有统计学意义(P<0.05)。PR在蜕膜间质细胞核中的表达A组较其他组表达明显降低,差异有统计学意义(P<0.05);B组较C、D组表达降低,差异有统计学意义(P<0.05)。结论不同剂量的米非司酮对人工流产术后不全流产残留物中β-hCG的表达影响不明显。对蜕膜细胞中的ER、PR表达有抑制作用,此抑制作用可能是米非司酮治疗不全流产的作用机制之一。1 400 mg米非司酮治疗效果最显著。 展开更多
关键词 米非司酮 不全流产 绒毛膜促性腺激素-βbeta (βbeta -hCG) 雌激素受体(er) 孕激素受体(PR)
下载PDF
逍遥丸合六味地黄丸对原因不明月经过少子宫内膜细胞ER、VEGF和KDR表达影响 被引量:12
12
作者 乐爱文 申旋 +4 位作者 单莉莉 肖天慧 卓蓉 熊慧娟 王中海 《生物学杂志》 CAS CSCD 2012年第3期48-50,共3页
探讨逍遥丸合六味地黄丸治疗原因不明月经过少的机理。原代培养原因不明月经过少病人的子宫内膜,采用免疫细胞化学进行细胞鉴定。空白对照组,高剂量组,中剂量组,低剂量组,雌激素组。免疫蛋白质斑迹法观察子宫内膜细胞的雌激素受体(ER)... 探讨逍遥丸合六味地黄丸治疗原因不明月经过少的机理。原代培养原因不明月经过少病人的子宫内膜,采用免疫细胞化学进行细胞鉴定。空白对照组,高剂量组,中剂量组,低剂量组,雌激素组。免疫蛋白质斑迹法观察子宫内膜细胞的雌激素受体(ER)、血管内皮生长因子(VEGF)及其受体(KDR)表达改变。逍遥丸合六味地黄丸能增强子宫内膜细胞的ER、VGER和KDR表达。逍遥丸合六味地黄丸可能通过提高子宫内膜组织中ER、VEGF和KDR治疗原因不明月经过少。 展开更多
关键词 原因不明月经过少 血管内皮生长因子 雌激素受体
下载PDF
新型雌激素受体ER-α36与乳腺癌 被引量:12
13
作者 廉馨 史丹 李洪艳 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2015年第1期34-37,共4页
雌激素受体(estrogen receptor,ER)是诊断和治疗乳腺癌的分子标志和靶点.雌激素受体包括ER-α和ER-β,其中ER-α有ER-α66、ER-α46和ER-α36三种亚型.ER-α36作为新型雌激素受体,参与膜起始的雌激素信号或非基因组雌激素信号转导,在肿... 雌激素受体(estrogen receptor,ER)是诊断和治疗乳腺癌的分子标志和靶点.雌激素受体包括ER-α和ER-β,其中ER-α有ER-α66、ER-α46和ER-α36三种亚型.ER-α36作为新型雌激素受体,参与膜起始的雌激素信号或非基因组雌激素信号转导,在肿瘤细胞的增殖、分化、侵袭和转移等过程中发挥作用.胃癌、子宫内膜腺癌、前列腺癌、尤其是乳腺癌的发生发展与ER-α36密切相关.本文介绍了ER-α36的结构域特点,ER-α36介导的信号通路及ER-α36在乳腺癌治疗中的作用研究进展. 展开更多
关键词 雌激素受体 雌激素受体α36 乳腺癌
下载PDF
ER和PRmRNAs在内异症子宫内膜表达的变化 被引量:3
14
作者 郑辉 李洪义 +2 位作者 王自能 柏志全 卢晓晔 《中国应用生理学杂志》 CAS CSCD 北大核心 2004年第2期194-196,共3页
目的 :探讨雌激素受体 (ER)和孕激素受体 (PR)在子宫内膜异位症 (内异症 )子宫内膜的表达。方法 :利用大鼠内异症动物模型 ,采用逆转录聚合酶链反应 (RT PCR)技术 ,检测子宫内膜ER和PRmRNAs的表达情况。结果 :内异症模型组大鼠异位内膜E... 目的 :探讨雌激素受体 (ER)和孕激素受体 (PR)在子宫内膜异位症 (内异症 )子宫内膜的表达。方法 :利用大鼠内异症动物模型 ,采用逆转录聚合酶链反应 (RT PCR)技术 ,检测子宫内膜ER和PRmRNAs的表达情况。结果 :内异症模型组大鼠异位内膜ER、PRmRNAs的表达低于在位内膜和对照组正常子宫内膜 ,与后两者比较差异有显著性意义 (P <0 .0 1) ;而模型组在位内膜ER、PRmRNAs的表达与正常对照组比较差异无显著性意义 (P >0 .0 5 )。内异症模型组异位内膜ER/PRmRNA比值大于在位内膜和正常子宫内膜ER/PRmRNA比值 (P <0 .0 1)。结论 :内异症大鼠异位内膜ERmRNA表达的相对增高在内异症的发生与发展中起着一定的作用。 展开更多
关键词 子宫内膜异位症 子宫内膜 雌激素受体 孕激素受体 mRNA er PR
下载PDF
ER、PR以及HER-2在乳腺癌原发灶及复发灶间表达差异及其临床意义 被引量:10
15
作者 杜江 董朝 +1 位作者 钟红 马斌林 《新疆医科大学学报》 CAS 2013年第5期653-655,共3页
目的探讨复发转移乳腺癌病例原发灶与复发转移灶之间存在的受体差异及其临床意义。方法采用免疫组织化学方法检测45例复发转移乳腺癌病例中雌激素受体(estrogen receptor,ER)、孕激素受体(proges-terone receptor,PR)以及人表皮生长因... 目的探讨复发转移乳腺癌病例原发灶与复发转移灶之间存在的受体差异及其临床意义。方法采用免疫组织化学方法检测45例复发转移乳腺癌病例中雌激素受体(estrogen receptor,ER)、孕激素受体(proges-terone receptor,PR)以及人表皮生长因子受体2(human epidermal growth factor receptor-2,HER-2)在原发灶与复发转移灶之间的表达差异。结果在原发灶中,27例患者ER阳性,阳性率为60.00%,在复发转移灶中16例患者ER阳性,阳性率为35.56%,原发灶中ER阳性率高于复发转移灶ER的阳性率,差异有统计学意义(P<0.05);在45例乳腺癌病例原发病灶中,PR、HER-2阳性分别为23例(51.11%)、9例(20.00%),复发转移病灶中,PR、HER-2阳性分别为21例(46.67%)、10例(22.22%),原发灶与复发转移灶中PR、HER-2表达差异无统计学意义(P>0.05)。在45例乳腺癌病例中,ER由阳性转为阴性者共9例,由阴性转为阳性者2例,总的变化例数为11例,变化率为24.44%;PR由阳性转为阴性者共8例,由阴性性转为阳性者共5例,总的变化数为13例,变化率为28.89%;有4例HER2阴性患者在复发转移灶中过表达,另外有3例患者转化为转移灶的阴性或低表达,总的变化数为7例,变化率为15.56%。结论 ER在乳腺癌原发灶以及转移复发灶之间的表达存在差异,对于乳腺癌复发转移患者制定治疗方案时,应充分考虑到受体变化的影响。 展开更多
关键词 乳腺癌 雌激素受体(er) 孕激素受体(PR) 人表皮生长因子受体2(Her-2) 免疫组织化学
下载PDF
食管癌及癌前病变中p73、p53、ER和PR的表达及临床价值 被引量:5
16
作者 樊圣 卫建平 +4 位作者 郭晓光 杨艳霞 白雪峰 刘翠香 周松 《临床肿瘤学杂志》 CAS 2006年第6期461-466,共6页
目的:检测p73、p53、ER和PR在食管正常粘膜、单纯性增生、非典型增生及食管癌的表达及其相关性和临床病理意义,为食管癌早期诊断、预后判断、临床治疗提供有意义的生物学指标。方法:收集40例原发性食管鳞癌,14例非典型增生,14例单纯性... 目的:检测p73、p53、ER和PR在食管正常粘膜、单纯性增生、非典型增生及食管癌的表达及其相关性和临床病理意义,为食管癌早期诊断、预后判断、临床治疗提供有意义的生物学指标。方法:收集40例原发性食管鳞癌,14例非典型增生,14例单纯性增生和14例正常组织,采用免疫组化(S-P)方法检测p73、p53基因蛋白、雌激素受体(ER)和孕激素受体(PR)的表达。结果:p73、p53、ER和PR在食管癌、非典型增生、单纯性增生及正常组织中表达率分别为55·0%、21·4%、0%、0%;67·5%、35·7%、7·0%、0%;55·0%、21·4%、14·3%、0%;57·5%、14·3%、0%、0%。p73组从癌到正常组织的不同阶段的表达,整组比较经确切概率检验有显著性差异(P<0·001),分组比较在食管癌与非典型增生中经χ2检验有统计学意义(P<0·05),p53、ER和PR组的结果与此相似,p73与ER、PR在食管鳞癌的阳性表达具有相关性(P<0·05),与年龄、性别、肿瘤分化程度、有无淋巴结转移和浸润深度无相关性(P>0·05);ER阳性在年龄大于60岁与小于60岁比较有显著性差异(P<0·05),与有无淋巴结转移比较有显著性差异(P<0·05)。结论:p73在食管癌高表达,在正常组织与单纯组织增生无表达的特性,提示有可能成为一个新的肿瘤诊断的标记物;p73和ER、PR阳性表达在食管癌中存在相关性;p73和ER、PR联合检测可能有助于食管癌的早期诊断,判断预后,指导治疗。 展开更多
关键词 食管鳞癌 P53 P73 雌激素受体(er) 孕激素受体(PR)
下载PDF
ER/PR^+和HER2^-型乳腺癌患者免疫组化指标的列线图预后模型 被引量:6
17
作者 吴莹 洪晏 +2 位作者 谢轶群 李曦洲 刘洋 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2018年第9期934-939,共6页
目的:探讨改良雌激素受体(estrogen receptor,ER)/孕激素受体(progesterone receptor,PR)阳性(^+)及人类表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)阴性(-)(ER/PR^+、HER2-)型乳腺癌患者的传统预后模型,满足目... 目的:探讨改良雌激素受体(estrogen receptor,ER)/孕激素受体(progesterone receptor,PR)阳性(^+)及人类表皮生长因子受体2(human epidermal growth factor receptor 2,HER2)阴性(-)(ER/PR^+、HER2-)型乳腺癌患者的传统预后模型,满足目前的临床实际需求。方法:选取了2009年1月至2009年12月上海市黄浦区中心医院乳腺外科收治的335例ER/PR^+、HER2-型乳腺癌患者。将97个变量纳入模型,采用SCAD变量选择的方法,在充分考虑协变量是否存在对数线性关系、非对数线性关系(分段线性关系)临界值的合理确定、共线问题后,构建一个新的ER/PR^+、HER2-型乳腺癌患者传统免疫组化指标的Cox回归预后模型,并进一步建立其列线图模型;在此基础上建立了术后1、3和5年生存概率的列线图;并通过比较模型的区分度(discrimination)和校准度(calibration)来评价模型的预测能力。结果:通过乳腺癌预后建立Cox回归模型结果显示,患者的预后与组织级别、淋巴结转移、Ki67、PR和年龄等因素有关;其中组织级别和淋巴结转移对风险比的影响呈对数线性关系,Ki67、PR和年龄对风险比的影响呈非对数线性关系,其合理临界值分别为Ki67(60%)、PR(20%)和年龄(55岁)。该模型术后1、3和5年的ROC曲线下面积(AUC值)均高于0.85,说明该Cox回归模型具有较高的区分度。该模型Gr?nnesby-Borgan拟合优度检验统计量值为1.37、对应的P值为0.5,说明该Cox回归模型有较好的校准度。结论:通过改良ER/PR^+和HER2-型乳腺癌患者的传统预后模型,建立患者术后1、3和5年生存概率的列线图,能准确、直观、有效地预测患者的生存概率,对乳腺癌患者临床治疗有较好的指导意义。 展开更多
关键词 乳腺癌 雌激素受体 孕激素受体 人类表皮生长因子受体2 传统免疫组化指标 列线图 预后模型
下载PDF
乳腺癌耐药细胞ER表达状态影响细胞对屈洛昔芬和阿霉素的敏感性 被引量:3
18
作者 高海东 孙靖中 +1 位作者 毕冬松 马榕 《癌症》 SCIE CAS CSCD 北大核心 2003年第4期376-379,共4页
背景与目的:雌激素受体(estrogenreceptor,ER)阳性乳腺癌细胞株来源的耐药细胞株中,ER表达缺失或下降,且细胞生长速度减慢。本文的目的是研究MCF-7/Adr乳腺癌耐药细胞株中ER表达状态与细胞对屈洛昔芬(droloxifene,Dro)和阿霉素(Adriamyc... 背景与目的:雌激素受体(estrogenreceptor,ER)阳性乳腺癌细胞株来源的耐药细胞株中,ER表达缺失或下降,且细胞生长速度减慢。本文的目的是研究MCF-7/Adr乳腺癌耐药细胞株中ER表达状态与细胞对屈洛昔芬(droloxifene,Dro)和阿霉素(Adriamycin,Adr)敏感性之间的关系。方法:Westernblot法检测MCF-7/Adr及其亲本MCF-7细胞中ER蛋白的表达,构建ER的真核细胞表达质粒(pCER),利用LipofectAMINETM将ER基因导入MCF-7/Adr细胞,经G418抗性筛选获得阳性克隆(MTER/Adr),PCR、Westernblot法鉴定并检测ER基因的整合和蛋白表达,流式细胞仪检测细胞周期变化,MTT法检测Dro及Adr对细胞增殖的影响。结果:在MCF-7细胞中可检测到ER蛋白的表达,而MCF-7/Adr细胞中使用Westernblot检测不到ER蛋白的表达。成功构建真核细胞表达质粒pCER并转染MCF-7/Adr细胞,阳性克隆MTER/Adr整合了ER基因并获得表达。经MTT分析,10μmol/LDro对MCF-7细胞的生长有明显的抑制作用,而到20μmol/L时对MCF-7/Adr细胞的生长有抑制作用。ER转染MCF-7/Adr细胞后,15μmol/L的Dro对其生长出现抑制作用,使细胞多分布于G0/G1期。同时细胞对Adr的敏感性下降。结论:MCF-7/Adr细胞中ER的丢失引起细胞对以ER为靶点的Dro治疗不敏感。 展开更多
关键词 乳腺肿瘤 雌激素受体 耐药性 内分泌治疗
下载PDF
乳腺癌超声特征与ER、PR、C-erbB-2表达的相关性分析 被引量:9
19
作者 陈剑琼 孙国平 王露 《安徽医学》 2011年第12期2058-2060,共3页
目的探讨乳腺癌超声表现与ER、PR和C-erbB-2表达的关系及其临床意义。方法对97例病理证实为乳腺癌患者的彩色多普勒超声表现与病理切片ER、PR、C-erbB-2免疫组织化学染色结果进行回顾性分析。结果①乳腺癌肿块的大小与ER、PR、C-erbB-2... 目的探讨乳腺癌超声表现与ER、PR和C-erbB-2表达的关系及其临床意义。方法对97例病理证实为乳腺癌患者的彩色多普勒超声表现与病理切片ER、PR、C-erbB-2免疫组织化学染色结果进行回顾性分析。结果①乳腺癌肿块的大小与ER、PR、C-erbB-2表达相关性分析差异无统计学意义(P>0.05)。②乳腺癌肿块边缘、血流信号分级及腋窝淋巴结转移与ER、PR、C-erbB-2的表达相关,差异有统计学意义(P<0.05)。结论乳腺癌超声表现与ER、PR、C-erbB-2表达有一定的相关性,二者结合分析为乳腺癌的临床诊断、治疗、预后提供重要依据。 展开更多
关键词 乳腺癌 超声 雌激素受体(er) 孕激素受体(PR) C-erBB-2
下载PDF
p120ctn和Her-2在ER、PR阴性乳腺癌组织中的表达及临床意义 被引量:3
20
作者 邹三鹏 林珊 +4 位作者 陈涛 胡刚 周金梅 黄浩 熊柳冰 《现代肿瘤医学》 CAS 2016年第15期2401-2405,共5页
目的:探讨连环蛋白p120(p120ctn)和人表皮生长因子受体-2(Her-2)在ER、PR阴性乳腺癌组织中的表达情况及其与临床病理特征的关系。方法:用免疫组化方法检测87例雌激素受体(ER)、孕激素受体(PR)阴性乳腺癌组织及其中41例癌旁乳腺组织和33... 目的:探讨连环蛋白p120(p120ctn)和人表皮生长因子受体-2(Her-2)在ER、PR阴性乳腺癌组织中的表达情况及其与临床病理特征的关系。方法:用免疫组化方法检测87例雌激素受体(ER)、孕激素受体(PR)阴性乳腺癌组织及其中41例癌旁乳腺组织和33例乳腺纤维腺瘤组织中Her-2及p120ctn的表达情况。结果:87例ER、PR阴性乳腺癌组织中p120ctn蛋白在细胞膜异常表达率为63.2%(55/87),Her-2阳性表达为60.9%(53/87)。41例癌旁乳腺组织中p120ctn蛋白在细胞膜异常表达率为7.3%(3/41),Her-2无阳性表达;33例乳腺纤维腺瘤组织中p120ctn异常表达率为9.1%(3/33),Her-2亦无阳性表达。p120ctn异常表达、Her-2阳性表达在ER、PR阴性乳腺癌组织与癌旁乳腺组织、乳腺纤维腺瘤组织中差异显著(P=0.000)。p120ctn的异常表达和Her-2的阳性表达与癌组织的组织学分级和淋巴结转移均显著相关(P<0.05),与患者的月经、年龄、肿瘤大小和临床分期无关(P>0.05)。p120ctn的异常表达和Her-2的阳性表达在ER、PR阴性乳腺癌组织中呈显著正相关关系(r=0.952,P=0.000)。结论:p120ctn的异常表达和Her-2阳性表达在ER、PR阴性乳腺癌的发生、发展中可能起到协同作用。联合检测对评估预后以及为基因靶向治疗提供初步依据。 展开更多
关键词 乳腺肿瘤 连环蛋白p120ctn 人表皮生长因子受体-2 雌激素受体 孕激素受体 免疫组织化学
下载PDF
上一页 1 2 13 下一页 到第
使用帮助 返回顶部